COMMUNIQUÉS West-GlobeNewswire

Probiodrug AG: Probiodrug reports Third Quarter 2017 Business Update
30/11/2017
HALLE (SAALE), Germany, 30 November 2017 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), today announces its third quarter [...]
3D Signatures Reports First Quarter Financial Results for Fiscal 2018
30/11/2017
TORONTO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a proprietary software platform based on the three- [...]
Teladoc Announces Pricing of Sale of Shares of Common Stock
30/11/2017
PURCHASE, NY, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE: TDOC ) (“Teladoc”) today announced the pricing of the previously announced offering of shares of its common stock, which includes 3,454,000 shares [...]
Dr. Stephen Hudis Sworn in as Vice President of the American College of Prosthodontists
29/11/2017
Chicago, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Stephen I. Hudis, DDS, FACP , was sworn in as Vice President of the American College of Prosthodontists (ACP) during the 47 th Annual Session of the ACP held in San Francisco, [...]
Novartis announces Phase III STRIVE data published in NEJM demonstrating significant and sustained efficacy of erenumab in migraine prevention
29/11/2017
Patients with episodic migraine taking erenumab reported significant and meaningful benefits over six months, with reduced migraine days and acute medication use Fifty percent of patients taking erenumab 140mg had their [...]
Forward Pharma Files Further Written Submissions in the European Opposition Proceeding for the EP2801355 Patent in Preparation for the Oral Hearing in January 2018
29/11/2017
COPENHAGEN, Denmark, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP ) (“Forward” or the “Company”) today announced the filing of further written submissions in the European Opposition Proceeding for [...]
Veritas Pharma Appoints of BC's "Top 40 Under 40" Robert Dawson – a Highly Regarded Marketing & Innovation Expert to Its Advisory Board
29/11/2017
VANCOUVER, British Columbia, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) announces the appointment of Mr. Robert “Rob” Dawson to its [...]
Golden Leaf Reports Third Quarter 2017 Results
29/11/2017
TORONTO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced its [...]
TRACON Doses First Patient in Phase 1b Study of TRC105 with Opdivo® in Patients with Lung Cancer
29/11/2017
SAN DIEGO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]
Adamis Pharmaceuticals Submits Prior Approval Supplement to FDA for the Pediatric Version of Symjepi
29/11/2017
SAN DIEGO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP ) today announced the submission of a prior approval supplement to the U.S. Food and Drug Administration (“FDA”) for a [...]
Genesis Healthcare, Inc. Receives Continued Listing Standard Notice From the NYSE
29/11/2017
KENNETT SQUARE, Pa., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Genesis HealthCare (“Genesis”) (NYSE: GEN ), one of the largest post-acute care providers in the United States, today announced that it received written [...]
Genmab Achieves USD 20 Million Milestone in Daratumumab Collaboration with Janssen and Updates Financial Guidance
29/11/2017
Company Announcement Genmab to receive USD 20 million milestone payment from Janssen Milestone triggered by progress in the Phase III study of daratumumab in combination with cyclophosphamide, bortezomib and [...]
Amphastar Announces Approval for Medroxyprogesterone Acetate Injectable Suspension, USP
29/11/2017
RANCHO CUCAMONGA, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH ) announced that today the U.S. Food and Drug Administration (“FDA”) granted approval of two abbreviated new [...]
Establishment Labs and OBP Medical Announce Partnership to Deliver Innovative New Tool for Advanced Breast Aesthetics Procedures
29/11/2017
NEW YORK, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced today the launch [...]
Sanofi updates information on dengue vaccine
29/11/2017
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi updates information on dengue vaccine New analysis of long-term Dengvaxia ® data found differences in vaccine performance based on prior dengue infection [...]
Sanofi actualise l'information concernant son vaccin contre la dengue
29/11/2017
Communiqué de presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi actualise l'information concernant son vaccin contre la dengue Les résultats d'une nouvelle étude de suivi à long terme de Dengvaxia ® font [...]
Purepoint Uranium Group Inc. Announces Private Placement and First Tranche Closing
29/11/2017
Not for Dissemination in the United States or through U.S. Newswire Services TORONTO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Purepoint Uranium Group Inc. (TSXV:PTU) (the “Company”) announced a non-brokered private placement [...]
bioAffinity Technologies Welcomes New Board Members
29/11/2017
SAN ANTONIO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics and therapeutics company, today announced the appointments of Stephen Squinto, Ph.D., and Gary Rubin, CPA, to [...]
Title21 Health Solutions® Announces ISBT 128 Compliance Service, Title21 Compliance Care™
29/11/2017
PLEASANTON, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Title21 Health Solutions, “Title21,” an innovator of integrated enterprise software for cell therapy and blood and marrow transplant programs supporting high-quality [...]

Pages